NTI Endorses Biosecurity Modernization and Innovation Act of 2026
webCredibility Rating
High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: Nuclear Threat Initiative
This NTI endorsement is relevant to AI safety insofar as it addresses dual-use biotechnology oversight and biosecurity-by-design principles that parallel governance challenges in AI; directly applicable to biosecurity and emerging technology policy discussions.
Metadata
Summary
The Nuclear Threat Initiative (NTI) endorses the bipartisan Biosecurity Modernization and Innovation Act of 2026, sponsored by Senators Cotton and Klobuchar, which aims to strengthen U.S. biosecurity through improved DNA synthesis screening, an innovation hub for biosecurity-by-design solutions, and streamlined federal oversight of dual-use bioscience research. The legislation seeks to close gaps in U.S. biotechnology oversight and align with NTI recommendations for congressional action on biosecurity.
Key Points
- •Bipartisan bill strengthens DNA synthesis sequence and customer screening as a near-term biosecurity risk-reduction measure.
- •Creates a government innovation hub bringing together commercial, academic, and government stakeholders to embed biosecurity by design.
- •Streamlines federal oversight of dual-use bioscience and biotechnology R&D to prevent accidental or deliberate harmful activities.
- •Aims to consolidate fragmented U.S. biosecurity approaches to enable responsible scientific progress and reinforce U.S. biotech leadership.
- •NTI views this as closely aligned with its own recommendations for congressional action to secure U.S. biotechnology.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| NTI | bio (Nuclear Threat Initiative - Biological Program) | Organization | 60.0 |
Cached Content Preview
NTI Endorses Biosecurity Modernization and Innovation Act of 2026
Close
News
Feb 4, 2026
NTI Endorses Biosecurity Modernization and Innovation Act of 2026
Share
-->
Twitter
Facebook
Linkedin
Email
NTI endorses the bipartisan Biosecurity Modernization and Innovation Act of 2026 , led by Senators Tom Cotton (R-AR) and Amy Klobuchar (D-MN). This bill creates an important opportunity to incentivize a safe and secure U.S. bioeconomy through strengthened biosecurity policy.
“The Biosecurity Modernization and Innovation Act represents a critical opportunity to embed biosecurity into the foundation of America’s strong and growing bioeconomy. By modernizing oversight and fostering collaboration across government, industry, and academia, this legislation helps ensure that scientific and technological progress will strengthen—not jeopardize—national and global security.”
— Hayley Anne Severance, acting vice president, NTI | bio
The legislation advances three core objectives essential to safeguarding innovation:
Strengths DNA synthesis sequence and customer screening as a near-term risk-reduction measure
Establishes an innovation hub within the U.S. government that brings together commercial, academic, and government stakeholders to develop, test, and deploy real-world solutions that embed biosecurity by design
Streamlines and strengthens federal oversight of dual-use bioscience and biotechnology research and development to protect against accidental or deliberate harmful activities, forming core pillars of a comprehensive national biosafety and biosecurity strategy.
The bill offers solutions to close gaps in U.S. biotechnology oversight and aligns closely with NTI | bio recommendations for Congressional action. By consolidating and modernizing fragmented approaches to biosecurity and biosafety, the legislation will enable responsible scientific progress, reinforce U.S. biotechnology leadership, and strengthen national and global security.
Stay Informed
s">Sign up for our newsletter to get the latest on nuclear and biological threats.
Sign Up
More News
Biological
Biosecurity
United States
NTI and CACDA Issue Joint Statement Calling for Stronger Biosecurity and Responsible AI-Biotechnology Innovation
News
Feb 18, 2026
NTI and CACDA Issue Joint Statement Calling for Stronger Biosecurity and Responsible AI-Biotechnology Innovation
Amid rapid advances in bioscience and as artificial intelligence reshapes global technological capabilities, the Nuclear Threat Initiative (NTI) and the China Arms Control and Disarmament Association (CACDA) are jointly calling for action to strengthen biosecurity and oversight and engage in re
... (truncated, 5 KB total)52979fc1da0446a8 | Stable ID: sid_FaRBBOa9jQ